This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Literature retrieved using the above keywords and published were included with a time limit from 1st January 2020 to 8th Aug 2024.ResultsThe ResultsThe bibliometric analysis of COVID-19 and SuddenCardiacDeath highlights key research trends from 2020 to 2024, revealing a rapid surge in scientific output during the pandemic.
Image courtesy of UCL Institute of Cardiovascular Science / James Tye milla1cf Tue, 12/19/2023 - 18:19 December 19, 2023 — A vest that can map the electrical activity of the heart in fine detail could potentially be used to better identify people at high risk of suddencardiacdeath , suggests a new study led by UCL researchers.
See My Comment in the June 1, 2020 post in Dr. Smith's ECG Blog — for review of Pleomorphic VT. Pleomorphic VT and SuddenCardiacDeath — Editorial by Liu and Josephson on potential mechanisms to explain the ECG appearance of Pleomorphic VT.
The guidelines for atrial fibrillation ( AF ) from the American Heart Association ( AHA ) in 2019 and the European Society of Cardiologists ( ESC ) in 2020 recommend continued monitoring and evaluation for patients with atrial high-rate episodes (AHRE), with the ESC noting a preference for remote monitoring.5,6 Margolis G, et al.
Subcutaneous ICDs (S-ICD) are a treatment option for the prevention of suddencardiacdeath in pediatric patients. However, in a 2020 multicenter study of pediatric patients with a S-ICD found a risk of inappropriate shock (IS) double that of a large adult study. The S-ICD has limited programming options.
Hypertrophic cardiomyopathy (HCM)-related suddencardiacdeath (SCD) rates with contemporary management are low; however, high-intensity exercise can induce fatal arrhythmias in HCM patients. Thus, current guidelines recommend avoiding high-intensity exercise in HCM patients at high risk for SCD1,2.
Methods Patients were retrospectively evaluated between January 2012 and June 2020. Objectives To describe a cohort of patients with arrhythmogenic left ventricular cardiomyopathy (ALVC), focusing on the spectrum of the clinical presentations. Significant right ventricular involvement was an exclusion criterion.
Methods The Outcomes Registry for Cardiac Conditions in Athletes was a nationwide prospective multicentre observational cohort study that captured testing and outcomes data from 45 institutions (September 2020–June 2021). Athletes with an ECG and transthoracic echocardiogram (TTE) and no pre-existing conditions were included.
Background Consensus guidelines support the use of implanted cardioverter-defibrillators (ICD) for primary prevention of suddencardiacdeath in patients with either non-ischaemic or ischaemic cardiomyopathy with left ventricular ejection fraction (LVEF) ≤35%.
Secondary outcomes included trends of suddencardiacdeath, appropriate/inappropriate shocks, and ICD-related complications.RESULTS:In total, 234 studies (N=92 500, 514 748 patient-years) met inclusion criteria. There was a significant decline in the rates of suddencardiacdeath from 1990 (0.84%/y) to 2020 (0.31%/y).CONCLUSIONS:Dramatic
The patient did not have a positive family history of epilepsy, suddencardiacdeath (SCD) or recurrent syncope. P.S.: For another clinical example of how EASY-it-is to overlook a long QTc if one is not systematic in approach — Please check out the May 3, 2020 post in Dr. Smith's ECG Blog.
We can also use intracardiac echocardiography to guide and facilitate the procedure with real-time visualisation of the cardiac structures being treated.” 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). Eur Heart J.
Finally, LV-GLS provided incremental prognostic value over 2020 American College of Cardiology (ACC)/American Heart Association (AHA) risk model (log-likelihood ratios, -262.2 004 for 2020 AHA guideline and 2022 ESC guideline, respectively).Conclusion:Feature to 3.36]) after adjustment for known risk factors. vs -266.2; vs -264.9;
The granulomatous inflammation affects the heart, causing an infiltrative cardiomyopathy The most common manifestations of cardiac sarcoidosis are atrioventricular (AV) block and ventricular tachyarrhythmias (VT). SCD (suddencardiacdeath) from sarcoid heart disease is thought to be caused by either from high-grade AV block or VT.
HCM is estimated to occur in ~1 in 500 young adults , making it among the most common inherited cardiac disorders. It is the most common underlying cause of suddencardiacdeath ( SCD ) in asymptomatic young individuals — which raises the question of whether to screen those involved in regular ( high performance ) athletic activity?
Brugada syndrome is thought to account for about one fourth of suddencardiacdeaths in individuals with structurally normal heart. 2020 Sep;31(9):2474-2483. Even though mutations in other channels have been described in Brugada syndrome, only those in SCN5A gene are considered to be definitely disease causing.
CVrg: Heart Failure 2020-2029, p 44; Maron et al. Risk factors of suddencardiacdeath in hypertrophic cardiomyopathy. References: Maron M, et al. Impact of Aficamten on Disease and Symptom Burden in Obstructive Hypertrophic Cardiomyopathy: Results from SEQUOIA-HCM. Hong Y, Su WW, Li X. Current Opinion in Cardiology.
Autopsy studies were done for all suddendeath cases after COVID-19 vaccination in Korea because of a national compensation program for vaccine injuries. This identified eight cases of suddencardiacdeath as caused by VRM that were not known until the autopsy was performed.
2020) The un-disputable fact is ischemic DCM has a target to treat, though it is termed as cardiomyopathy. Bardy GH, Lee KL, Mark DB, Poole JE, SuddenCardiacDeath in Heart Failure Trial (SCD-HeFT) Investigators. (N Engl J Med 2016; 375:1221-1230) Why ICD doesn’t work well in NDCM ? Reference 1. N Engl J Med.
He said a screening test called cardiac-arrhythmic genome analysis is available in certain European centers. The role of the molecular autopsy in suddencardiacdeath in young individuals. Ref: Isbister, J.C., Semsarian, C. Nat Rev Cardiol 21 , 215–216 (2024). Pacing and Clinical Electrophysiology, 35(7), e210–e213.
21-23 hsCRP is nonspecific inflammatory marker and an acute phase reactant that predicts the likelihood of a heart attack, stroke, peripheral artery disease and suddencardiacdeath among healthy individuals with no history of CV disease, and recurrent events and death in patients with known ASCVD.22 Circulation.
Otherwise, no admission of CAD, HLD, or family history of suddencardiacdeath. He described the pain as “nagging,” and equally not exacerbated by any kind of movement. A pertinent medical history remarkable for HTN was disclosed, which was well controlled on Rx Olmesartan.
The limb lead abnormalities appear to be part of the Brugada pattern, as described in this article: Inferior and Lateral Electrocardiographic RepolarizationAbnormalities in Brugada Syndrome Discussion Brugada Type 1 ECG changes are associated with suddencardiacdeath (SCD) and the occurrence of ventricular dysrhythmias.
No family history of suddencardiacdeath, cardiomyopathy, premature CAD, or other cardiac issues. There is a literature on this subject ( GGF van der Schoot et al: Neth Heart J 28(6):301-308, 2020 — and — Egred et al — Postgrad Med 81(962): 741-745, 2005 — to name just 2 reports ). No similar symptoms in the past.
The authors are very careful to not use definitive causal terms, but it is pretty clear they strongly believe they are describing a new mechanism and novel etiology of suddencardiacdeath.
Most cases occurred in the older population, aged 65 years, comprising 78.70% of the total mortality (23 972/30 458). The male/female ratio for the average annual crude and agestandardized mortality rates was 1:0.98 and 1:0.75, respectively, whereas the urban/rural ratio was 1:1.61 and 1:1.40, respectively.
Background:Understanding the incidence, causes, and trends of suddencardiacdeath (SCD) among young competitive athletes is critical to inform preventive policies.Methods:This study included National Collegiate Athletic Association athlete deaths during a 20-year time frame (July 1, 2002, through June 30, 2022).
The incidence of suddencardiacdeath is over 300,000 in the United States. Inpatient implantation of secondary prevention implantable cardioverter defibrillator (ICD) is variable and subject to healthcare disparities.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content